MDT
Medtronic plc
Cash flow statement
| USDLine, in USD | Last 12 months | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 8.04B | 7.33B | 7.04B | 6.79B | 6.04B | 7.35B | 6.24B | 7.23B | 7.01B | 4.68B | 6.88B | 5.22B | 4.90B | 4.96B | 4.94B |
| 1.90B | 1.90B | 1.86B | 1.59B | 1.46B | 1.37B | 1.36B | 1.21B | 1.13B | 1.07B | 1.25B | 1.05B | 0.57B | 0.40B | 0.46B | |
| Free cash flow | 6.13B | 5.43B | 5.19B | 5.20B | 4.58B | 5.98B | 4.89B | 6.02B | 5.87B | 3.62B | 5.63B | 4.17B | 4.33B | 4.56B | 4.49B |
| Depreciation and amortization | 2.94B | 2.96B | 2.86B | 2.65B | 2.70B | 2.71B | 2.70B | 2.66B | 2.66B | 2.64B | 2.92B | 2.82B | 1.31B | 0.85B | 0.82B |
| Stock-based compensation | 496M | 457M | 429M | 393M | 355M | 359M | 344M | 297M | 290M | 344M | 348M | 375M | 439M | 145M | 152M |
| Buybacks | 1.18B | 1.04B | 3.24B | 2.14B | 0.65B | 2.54B | 0.65B | 1.33B | 2.88B | 2.17B | 3.54B | 2.83B | 1.92B | 2.55B | 1.25B |
| Dividends paid | 3.65B | 3.64B | 3.59B | 3.67B | 3.62B | 3.38B | 3.12B | 2.89B | 2.69B | 2.49B | 2.38B | 2.14B | 1.34B | 1.12B | 1.06B |
| Dividends per share | 2.85 | 2.84 | 2.80 | 2.76 | 2.72 | 2.52 | 2.32 | 2.16 | 2.00 | 1.84 | 1.72 | 1.52 | 1.22 | 1.12 | 1.04 |
| Free cash flow margin | 16.3% | 14.9% | 15.5% | 16.1% | 14.7% | 18.9% | 16.2% | 20.8% | 19.2% | 12.1% | 18.9% | 14.5% | 21.4% | 26.8% | 27.0% |